Cardiology and cardiac surgery elective care funding
Funding has been created to support cardiac networks implementing remote monitoring tools to support cardiology and cardiac surgery pathways through elective care recovery.
The funding will support provider organisations within the cardiac networks with managing the conditions of cardiology and cardiac surgery patients, pre and post-procedure, more quickly, effectively and safely. The remote monitoring tools to be implemented through the funding will help provide opportunities to spot early signs of deterioration sooner, for patients:
- on waiting lists
- recently discharged
- managing cardiovascular conditions at home
Applications from interested cardiac networks can be submitted between 16 July to 27 August 2021.
Each application must include:
- nominated lead cardiac centre and CCG to receive and host the funding on behalf of the network
- lead medical director and clinical lead who has developed or supported the application
- written confirmation from the nominated organisation finance lead on how the funding will be allocated
- commitment to spend the monies, implement the digitally-enabled intervention, and onboard a significant number of patients into the pathway by 31 March 2022.
Get involved and submit your application
The application form for the opportunity to receive cardiology and cardiac surgery elective care funding is available as a document that you can download and complete (ODT, 85 KB).
Once completed all forms must be returned by email to email@example.com by 27 August 2021 and include "Cardiology and cardiac surgery elective care - Adoption Fund Application (insert your ICS name)" .
Please ensure you have read the guidance criteria below to help prepare your application.
Guidance to support applications
Prerequisites and eligibility for the funding
There are a number of requirements for a cardiac network that must be met before their application can be shortlisted, deemed successful and the funding released. These relate to the ability of the network to deliver the digital tools and the intervention at pace and within the agreed timescales.
As a guide the following needs to be in place:
- An established cardiac network with strong governance.
- Commitment that all individual provider organisations within the cardiac networks to be involved.
- Confirmed senior responsible officer (SRO) at network level.
- Confirmed senior clinical leadership at the network level.
- SRO confirmed at the provider organisation levels.
- Essential project support identified, available and confirmed locally.
- Evidence of local information governance, IT and clinical safety support.
- Ability to proceed at pace and have commitment by all provider organisations in the network to individually or collaboratively complete procurement for a digital solution by 31 December 2021.
- Ability to implement the solution and onboard a significant number of patients onto the pathway by 31 March 2022.
- Ability and commitment to spend the NHSX funding by 31 March 2022.
Expectation of the cardiac networks
The networks will be required to commit to achieving the following by 31 March 2022:
- Sign a Memorandum of Understanding (MOU) that details the expectations and deliverables.
- Commit to freeing up resources locally and each provider organisations within the networks or at a network level conduct regular data collection as defined by NHSX and to submit relevant data to NHSX for the purposes of evaluation.
- Ability to proceed at pace and a commitment by all provider organisations in the network to individually or collaboratively complete a procurement for a digital solution by 31 December 2021.
- Ability to implement the solution and onboard an agreed number of patients into the pathway by 31 March 2022.
- Complete any procurements within the agreed timescales.
- Commit to spending the NHSX funds by 31 March 2022.
- Support the development of case studies.
- Agree to support other networks by sharing experiences and insights.
Expectation of NHSX
NHSX is looking to work with a maximum of four cardiac networks. The limit is set based on the level of funding available from NHSX this financial year 2021 to 2022, circa £3 million with funding of up to 750,000 for up to four networks.
The team will be available to offer advice and support along the journey from design, to procurement and delivery. Some examples of this include:
- support with market engagement to identify remote monitoring options
- support and advice for pathway design, workflow, assurance and evaluation
- regular catch ups to discuss process and troubleshooting
- linking networks together through facilitated events to share learning
- help to overcome any unexpected delays or obstacles
Applications to be submitted by the cardiac networks need to include how they will:
- accelerate the mobilisation and onboarding of cardiology and cardiac surgery patients pre and post-procedure
- generate data and learnings to inform an evaluation to help shape future scaling and implementation nationally from July 2022
- deliver at pace and have commitment by all provider organisations in the network to individually or collaboratively complete procurement for a digital solution by 31 December 2021
- implement the solution and onboard a significant number of patients onto the pathway by 31 March 2022
All applications will be assessed through an open and transparent process.
A condition of awarding the funding is that each network commits to collecting and submitting data and undertaking an evaluation of the agreed activity as per their submission.The likely timescale for this is for a start In March to April 2022 until the end of June 2022.
The scope of the evaluation will be developed in partnership and discussed in detail, agreed and finalised with the clinical networks and the cardiac delivery board over the coming weeks. It is likely we will seek to evaluate one or more of the following:
- Impact on end user experience both patient and health care professional.
- Impact on staff productivity for example time saved, better use of staff roles.
- Level of uptake of the intervention amongst patients.
- Impact in patient activation.
- Impact on unplanned attendances and admissions.
- Impact on patient morbidity.
- Impact on outpatient appointments.
- Value for money.
- Long term value for the NHS.
- Other outcomes as locally defined.
One or more case studies may also be required to share best practice by June 2022.
These metrics are subject to further clarification and may be amended over the course of the financial year 2021 to 2022 as new data emerges.
Evaluation criteria and scoring explained
Stage 1: Evaluation
The aim of this stage is to perform a detailed review of the responses provided by each of the applications. Applications will be scored in accordance with the matrix indicated in table 2 below. Scores will be allocated based on the quality of the response, guidance for which is provided in table 3 below. Based on the evaluations, the shortlisted proposals form this stage will go through to the final stage.
The aim of this stage is to perform a detailed review of the responses provided by each of the applications. Application responses to questions 2 to 6 will be scored in accordance with the scoring matrix indicated in table 1 below. Each question has a series of bullet points in the application form. Answers should consider each bullet point, this is not an exhaustive list.
Questions 1.1, 1.2, 1.3 and 1.4 will score a ‘0’ if no answer is provided or a ‘3’ if a suitable answer is provided. If any application receives a ‘0’ against any of the questions, this will be an automatic fail and the application will not be considered further.
Based on the evaluations, the shortlisted proposals from this stage will go through to the final stage. Questions will be evaluated by a multidisciplinary team, to include clinicians and programme/project management experts.
Stage 2: Clarification Interview
This stage is not scored, however responses given at this stage may lead to an adjustment in the scores made in Stage 1. The aim of this stage is to meet with the applicants virtually, in order to discuss the application and for the assessors to have the opportunity to ask any clarification questions.
|No answer||No response provided||0|
|Well below expectations||Limited information provided, or a response that is inadequate and falling well below expectation||1|
|Below expectations||There are reservations due to falling below expectations||2|
|Meets expectations||An acceptable response submitted that meets expectations in terms of the level of detail, and relevance. As well as expected value add||3|
|Above expectations||A good response submitted in terms of detail and relevance, that is above expectation, and is above expectation in terms of perceived value add||4|
|Significantly above expectations||An excellent response submitted in terms of detail and relevance that is significantly above expectation, and is significantly above expectation in terms of perceived value add||5|
Allocation of funding
Cardiac networks will be able to submit applications for funding to support the acceleration, mobilisation and onboarding of cardiology and cardiac surgery patients within their networks.
Funding will be allocated based on:
- successful scoring during the application evaluation process
- a commitment and ability to spend the funding and deliver by 31March 2022
- a commitment to collect data and report on the agreed activity in line with details in this document
- a clear view on the sustainability of the programme once funding has ceased
All applicants need to ensure that submissions are registered for consideration in line with the deadline dates set out below.
- Applications open
- Information webinar on 21 July from 2.45pm to 3 45pm
- Information webinar on 29 July from 1pm to 2pm
- Deadline for applications to be submitted
- Shortlisted applicants notified
- Shortlisted applicants may be asked to submit additional information and invited to meetings with NHSX
- Final decision made and successful applicants informed
- Letter of intent issued by NHSX to secure funding
- Funding to be deployed by NHSX
- Local procurement commences
October to November 2021
Local procurement ends
Installation of digital tools
January to March 2022
Onboarding of patients